ArticleScientific reports2026
Integrated LiP-MS and quantitative proteomics reveal coordinated alterations in protein conformation and expression across tumor and peritumoral regions in hepatocellular carcinoma.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Hepatocellular carcinoma (HCC) exhibits substantial molecular heterogeneity, yet protein-level alterations beyond abundance remain insufficiently characterized. Here, we integrated limited proteolysis mass spectrometry (Lip-MS) with 4D label-free quantitative proteomics to investigate conformational accessibility and protein abundance across tumor, peritumoral-near, and peritumoral-far tissues from HCC patients. Differential LiP peptides identified by both DDA and DIA corresponded to 725, 674, and 33 differentially conformed proteins in the Tumor vs. Peritumor-far, Tumor vs. Peritumor-near, and Peritumor-near vs. Peritumor-far comparisons, respectively. Quantitative proteomics identified 405, 365, and 4 differentially expressed proteins in the corresponding comparisons. Integrated analysis identified 488 and 469 conformation-specific altered proteins (CSAPs), which showed altered conformational accessibility without significant abundance changes, and 237 and 205 conformation-expression coupled proteins (CECPs) in the two tumor-involved comparisons. LiP peptide and protein abundance changes were positively correlated, with Spearman coefficients of 0.69-0.72, and more than 99% of CECPs showed concordant directions. Among them, 169 region-conserved CECPs (rcCECPs) were predominantly associated with metabolic and redox-related pathways. Protein-protein interaction analysis identified 30 hub rcCECPs. ACLY, ALDH18A1, GMPS, and DHX9 showed increased representative LiP peptide signals and protein abundance, elevated transcript expression in HCC, and associations with poorer overall survival. Peptide mapping further localized their differential LiP signals to specific sequence regions and annotated domains. Collectively, these findings provide an integrated view of regional conformational accessibility and protein abundance alterations in HCC and identify candidate proteins for further structural and functional investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.